Medinotec (MDNC) Profit After Tax Growth (1y) (2023 - 2026)
Analysis
Medinotec (MDNC) Profit After Tax Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 18.51% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.26% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.84% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -27.98% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.92% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 95.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 95.12% |
| Feb 28, 2026 | -85.72% |
| Nov 30, 2025 | 113.62% |
| Aug 31, 2025 | 26.26% |
| May 31, 2025 | 30.48% |
| Feb 28, 2025 | 1,398.79% |
| Nov 30, 2024 | 163.02% |
| Aug 31, 2024 | 610.40% |
| May 31, 2024 | 30.37% |
| Feb 29, 2024 | 254.83% |
| Nov 30, 2023 | -908.75% |
| Aug 31, 2023 | 70.58% |
| May 31, 2023 | 206.03% |
| Feb 28, 2023 | 48.66% |